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Abstract
Substance use disorders are highly prevalent among forensic patients. They are associated with many challenges for patients
with these problems, including their ability to rehabilitate and successfully move through secure forensic mental health services,
as well as increasing risk for recidivism. Traditionally, forensic services have been more adept at focusing on and treating the
primary mental health diagnosis alone and have been less likely to prioritise this co-occurring patient need. Opportunities exist
to foster effective treatment strategies for substance use disorders, and past research has produced positive outcomes among
forensic patients in studies in both Australia and the UK to navigate a new course for patients with these problems. By provid-
ing empirically validated, co-produced and culturally competent treatment responses, forensic patients living with substance use
disorders will have the opportunity to significantly improve their wellbeing and progress through the system. They will also be
more prepared and equipped to face challenges upon discharge into the community, including increased availability of alcohol
and other drugs, social stigma and barriers to employment. Moreover, by prioritising effective substance use treatment pro-
grams during inpatient rehabilitation, services can reduce the levels of post-discharge recidivism. [McFadden D, Prior K,
Miles H, Hemraj S, Barrett EL. Genesis of change: Substance use treatment for forensic patients with mental health
concerns. Drug Alcohol Rev 2021]
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What Is the Scale and Impact of This Issue?
Substance use disorders are highly prevalent among
forensic patients (i.e. individuals who have committed
a crime and been found not guilty by reason of mental
illness). Between 60 and 75% of forensic inpatients
meet the DSM-IV and DSM-5 diagnostic criteria for
substance use disorder [1–4]. Although the link
between substance use and offending is acknowledged
[5,6], it has not always been accompanied by adequate
changes to forensic mental health service delivery [7].
There is a range of challenges faced by forensic
patients with substance use histories in the UK and
Australia; both during their treatment in forensic
services and upon their release into the community.
Forensic services tend to lack treatments that fully sup-
port patients in their rehabilitation, with treatments
varying in design and levels of sophistication [7–9].
The presence of severe, complex mental illness can
also prevent patients from engaging fully in rehabilita-
tion programs. This can combine with distrust of
authority and prohibit the formation of a strong thera-
peutic relationship, necessary and central to improved
outcomes [10,11].
Even when patients are treated within the forensic
mental health system and subsequently discharged, the
presence of a comorbid substance use disorder can
make living in the community challenging. Individuals
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with severe mental disorders can be at risk of engaging
in violent behaviour [12,13]. This could be due to the
impact of intoxication, withdrawal symptoms, depen-
dence and mental health symptoms all of which can
influence an individual’s ability to control their behav-
iour [14]. A long-term follow-up study of 550 forensic
patients found that having a history of substance use
problems was positively associated with reconviction
post-release [15]. Half (49%) of the patients were re-
convicted over the 20-year period [15]. Other studies
have found significant associations between drug and
alcohol use and reoffending post-discharge [16].
Forensic patients also experience severe discrimina-
tion when discharged into the community. It has been
argued that the stigmatisation of people with mental
disorders fuels the societal belief that mental disorders
and violence are strongly connected, for instance, a
community-based survey found that respondents were
more likely to predict someone would commit a crime
in the future if they had a mental illness than if they
did not have one [17]. The association between mental
health and criminal behaviour is largely influenced by
other factors, such as age, sex and educational level
[18], with studies demonstrating that only around one-
sixth (17%) of crimes committed by individuals with
mental illness are actually related to the symptoms of
their mental disorder [19]. Despite the overwhelming
majority of violent acts being committed by individuals
without mental illness [20], this prejudice continues to
have a detrimental impact on forensic patients
reintegrating into the community.
Collectively, these challenges can make a complex
rehabilitation pathway even more complicated. As
forensic patients with substance use disorders enter the
forensic system, they require treatments that ade-
quately address their presenting needs and equip them
for eventual discharge into the community, so they
aren’t further disadvantaged. Empirically validated, co-
produced (i.e. designed in collaboration with service
users) and culturally competent interventions targeted
at this group are needed to mitigate these challenges
and contribute to their recovery. However, it is
acknowledged that the social, political and institutional
obstacles to appropriate care continue to present a for-
midable challenge to health-care delivery within these
settings.
What Do We Know about the Treatment of
Substance Use Disorders among Forensic
Patients?
Substance use disorder treatment in non-forensic con-
texts provides a useful blueprint for the development
of robust and effective treatment strategies for forensic
populations. The efficacy of cognitive behavioural ther-
apy and motivational interviewing have been
established through numerous studies in inpatient psy-
chiatric settings [21,22] and among the general psychi-
atric population with substance use disorders [23–25].
In comparison, psychoeducation, the most frequently
employed approach in forensic settings, has been
shown to be largely ineffective, with no cognitive or
behavioural change [22,26,27].
Concerningly, we continue to see a stagnation in the
efforts to implement and evaluate these evidence-based
cognitive behavioural therapy and motivational inter-
viewing treatment approaches in forensic settings. As
previously outlined, substance use plays a major role in
the offending behaviour of many forensic patients, yet
it can be considered an afterthought to other clinical
issues facing forensic patients [2]. Some preliminary
studies have attempted to pave the way for progress in
this area [28–32]. However, progress in this area is
hampered by the lack of clinical studies and larger
randomised controlled trials with long-term follow ups
and control groups to confirm the efficacy findings.
Forensic services world-wide also struggle with a lack
of staff resources to provide up-to-date, evidence-
based treatment programs due to increasing caseloads
and competing workload priorities. Equally, many cli-
nicians in these settings do not have specialised exper-
tise in substance use treatment, as these are often
targeted in separate services.
Treatment Requirements for Forensic Patients:
A Diverse Approach for a Diverse Population
Forensic patients have a multitude of clinical charac-
teristics, which require specific treatment consider-
ations in order to ensure the treatment is not only
efficacious, but also acceptable to the patient cohort.
In the Australian forensic setting, Aboriginal and
Torres Strait Islander people, female patients and cul-
turally and linguistically diverse (CALD) groups
require these special considerations. Each group has
their own specific treatment needs, which need to be
addressed with evidence-based treatment programs.
For example, Aboriginal and Torres Strait Islander
patients are substantially overrepresented, making up
approximately 17–30% of the forensic population in
Australia [33,34] and for this reason, the importance
of cultural competence in mental health treatment is
now seen as a core requirement in forensic treatment
settings [34].
Another patient group that requires specific consid-
eration when designing and implementing forensic
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treatment services are female patients, who typically
make up a small yet important proportion of forensic
patients [29]. Female patients, who often have signifi-
cant histories of physical and sexual abuse [35],
require a space in which they can comfortably and
safely discuss their experience of trauma and its rela-
tionship to their substance use, preferably not in the
company of male forensic patients [36]. CALD groups
have their own individuals needs and their own cul-
tural perceptions of substance use and what is required
to start and stay on a road to recovery, which will often
involve family support from these same cultural back-
grounds [37]. Recovery plans generated as part of
these treatment programs must be cognizant of these
specific needs.
The Power of Co-production in Treatment
Development and Evaluation
‘Co-production’ in health care involves clinicians and
patients working together to design and deliver services
[38]. The use of co-production in the design, delivery
and evaluation of mental health services has gained sig-
nificant traction in recent years and is now seen as
integral to recovery-oriented services [39]. Those
engaging in co-production in research outline that it is
morally required of researchers to include feedback
and opinions of those whom the research is intended
to impact most [40]. This change has created a shift
from service users being passive recipients to co-
creators of their own treatment and care, empowering
them to lead in their own recovery. Despite research
indicating that service users have a strong desire to be
heard in relation to the provision of their treatment and also
research and evaluation [41-44], evidence of co-produc-
tion for substance using populations is scarce [45].
The differences in treating mental illness and sub-
stance use disorders are substantial and co-production
techniques must parallel this. Where mental illness has
become less stigmatised, this has not happened to the
same degree for substance use disorders [46]. Services
should engage an approach that is cognizant of the
need to empower service users to become the leaders
of their own health care.
What Next?
An opportunity exists to address substance use disor-
ders among forensic patients; a critical need that is
often unprioritised. Empirically supported treatment
strategies, with culturally competent and trauma-
informed approaches, education and training for staff
as well as co-designed and co-delivered programs, can
meet the rehabilitation needs of this group. The Sub-
stance Use Treatment Program trialled in the UK and
Australia [29,32] has shown some promise in
addressing these issues; however, further research is
required. Culturally competent treatment approaches
co-produced with Aboriginal and Torres Strait
Islander communities in Australian settings are of par-
ticular importance due to both the gaps in tailored ser-
vice provision and the rehabilitation challenges
experienced by this group in their communities upon
release. Forensic patients face significant challenges in
their rehabilitation pathway. Those with comorbid
substance use disorders could benefit greatly from
improved service provision, enabling them to reduce
their risk levels and move through secure care path-
ways at a quicker pace and to face the challenges asso-
ciated with daily life upon discharge. Forensic mental
health service providers can play a key role in provid-
ing effective treatment so that this population can
effectively survive and thrive in the community.
Acknowledgements
The project was supported by the NSW Health Educa-
tion and Training Institute via the Mental Health
Research Award and a NSW Mental Health Commis-
sion Lived Experience Framework grant.
Conflict of Interest
The authors have no conflicts of interest.
References
[1] Eagle K, Ma T, Sinclair B. Integrated substance use rehabilitation in a
secure forensic facility. J Forensic Prac 2019;21:50–60.
[2] Ogloff JR, Lemphers A, Dwyer C. Dual diagnosis in an Australian foren-
sic psychiatric hospital: prevalence and implications for services. Behav
Sci Law 2004;22:543–62.
[3] Van der Kraan J, Verkes RJ, Goethals K, Vissers A, Brazil I, Bulten E.
Substance use disorders in forensic psychiatric patients. Int J Law Psychi-
atry 2014;37:155–9.
[4] Ojansuu I, Putkonen H, Lähteenvuo M, Tiihonen J. Substance abuse
and excessive mortality among forensic psychiatric patients: a Finnish
Nationwide cohort study. Front. Psychiatry 2019;10:678.
[5] Derry A. The clinical response to substance use problems in forensic
mental health services. Br J Forensic Pract 2008;10:20–3.
[6] Link NW, Hamilton LK. The reciprocal lagged effects of substance use
and recidivism in a prisoner reentry context. Health Justice 2017;5:8.
[7] Mallion JS, Tyler N, Miles HL. What is the evidence for offense-specific
group treatment programs for forensic patients? Int J Forensic Ment
Health 2019;19:1–13.
[8] Sandbrook J, Clark T, Cocksedge KA. Addressing substance misuse in
medium secure settings in the UKand Ireland – a survey of current prac-
tice. J Forensic Pract 2015;17:192–203.
Drug Alcohol Rev. 3
© 2021 The Authors. Drug and Alcohol Review published by John Wiley & Sons Australia, Ltd on behalf of Australasian Professional Society on Alcohol and other Drugs.
[9] Whyte S, Harrison C. Substance misuse services in secure psychiatric
units. Med Sci Law 2004;44:71–4.
[10] Martin DJ, Garske JP, Davis MK. Relation of the therapeutic Alliance
with outcome and other variables: a meta-analytic review. J Consult Clin
Psychol 2000;68:438–50.
[11] Flückiger C, Del Re AC, Wampold BE, Horvath AO. The alliance in
adult psychotherapy: a meta-analytic synthesis. Psychotherapy (Chicago,
Ill) 2018;55:316–40.
[12] Fazel S, Gulati G, Linsell L, Geddes JR, Grann M. Schizophrenia and vio-
lence: systematic review and meta-analysis. PLoS Med 2009;6:e1000120-e.
[13] Wright S, Gournay K, Glorney E, Thornicroft G. Mental illness, sub-
stance abuse, demographics and offending: dual diagnosis in the
suburbs. J Forensic Psychiatry 2002;13:35–52.
[14] Ogloff JRP, Talevski D, Lemphers A, Wood M, Simmons M. Co-
occurring mental illness, substance use disorders, and antisocial person-
ality disorder among clients of forensic mental health services. Psychiatr
Rehabil J 2015;38:16.
[15] Davies S, Clarke M, Hollin C, Duggan C. Long-term outcomes after
discharge from medium secure care: a cause for concern. Br J Psychiatry
2007;191:70–4.
[16] Scott F, Whyte S, Burnett R, Hawley C, Maden T. A national survey of
substance misuse and treatment outcome in psychiatric patients in
medium security. J Forensic Psychiatry Psychol 2004;15:595–605.
[17] Nee C, Witt C. Public perceptions of risk in criminality: the effects of
mental illness and social disadvantage. Psychiatry Res 2013;209:675–83.
[18] Rueve ME, Welton RS. Violence and mental illness. Psychiatry 2008;5:
34–48.
[19] Peterson JK, Skeem J, Kennealy P, Bray B, Zvonkovic A. How often and
how consistently do symptoms directly precede criminal behavior among
offenders with mental illness? Law Hum Behav 2014;38:439–49.
[20] Varshney M, Mahapatra A, Krishnan V, Gupta R, Deb KS. Violence
and mental illness: what is the true story? J Epidemiol Community
Health 2016;70:223–5.
[21] Drake RE, Mueser KT, Brunette MF, McHugo GJ. A review of treat-
ments for people with severe mental illnesses and co-occurring substance
use disorders. Psychiatr. Rehabil. J. 2004;27:360–74.
[22] McMurran M. Expert paper: dual diagnosis of mental disorder and sub-
stance misuse. London: Department of Health, 2002.
[23] Hulse GK, Tait RJ. Five-year outcomes of a brief alcohol intervention for
adult in-patients with psychiatric disorders. Addiction 2003;98:1061–8.
[24] Martino S, Carroll K, Nich C, Rounsaville B. A randomized controlled
pilot study of motivational interviewing for patients with psychotic and
drug use disorders. Addiction 2006;101:1479–92.
[25] Satre DD, Weisner C, Travis A, Lu Y, Sterling SA, Leibowitz A. A ran-
domized clinical trial of motivational interviewing to reduce alcohol and
drug use among patients with depression (technical report). J Consult
Clin Psychol 2016;84:571.
[26] Ritchie G, Billcliff N, McMahon J, Thomson L. The detection and treat-
ment of substance abuse in offenders with major mental illness: an inter-
vention study. Med Sci Law 2004;44:317–26.
[27] Jeffery DP, Ley A, McLaren S, Siegfried N. Psychosocial treatment
programmes for people with both severe mental illness and substance
misuse. Cochrane Database Syst Rev 2000;2:238–58.
[28] Ritchie G, Weldon S, Freeman L, MacPherson G, Davies K. Outcomes
of a drug and alcohol relapse prevention programme in a population of
mentally disordered offenders. Br J Forensic Pract 2011;13:32–43.
[29] Miles H. “A new horizon?”: evaluation of an integrated Substance Use
Treatment Programme (SUTP) for mentally disordered offenders. Adv
Dual Diagn 2015;8:90–101.
[30] Miles H, Dutheil L, Welsby I, Haider D. ‘Just say no’: a preliminary
evaluation of a three-stage model of integrated treatment for substance
use problems in conditions of medium security. J Forensic Psychiatry
Psychol 2007;18:141–59.
[31] Derry A, Batson A. Getting out and staying out: does substance use
treatment have an effect on outcome of mentally disordered offenders
after discharge from medium secure service? Br J Forensic Pract 2008;
10:13–7.
[32] McFadden D, Prior K, Barrett EL. A Substance Use Treatment Pro-
gramme for mentally ill forensic patients in an Australian setting: a pilot
study of feasibility, acceptability and preliminary efficacy. Int J Ment
Health Addiction 2020. [Epub ahead of print].
[33] JHFMHN. Forensic mental health patient survey report. Sydney: Justice
Health and Forensic Mental Health Network, 2016.
[34] Durey A, Wynaden D, Barr L, Ali M. Improving forensic mental health
care for Aboriginal Australians: challenges and opportunities. Int J Ment
Health Nurs 2014;23:195–202.
[35] De Vogel V, Stam J, Bouman YHA, Ter Horst P, Lancel M. Violent
women: a multicentre study into gender differences in forensic psychiat-
ric patients. J Forensic Psychiatry Psychol 2016;27:145–68.
[36] Long CG, Fulton B, Fitzgerald K-A, Hollin CR. Group substance abuse
treatment for women in secure services. Ment Health Subst Use 2010;3:
227–37.
[37] Gainsbury SM. Cultural competence in the treatment of addictions: the-
ory, practice and evidence. Clin Psychol Psychotherap 2017;24:987–
1001.
[38] Batalden M, Batalden P, Margolis P et al. Coproduction of healthcare
service. Br Med J: Qual Saf 2016;25:509–17.
[39] Collins P, Naughton L, Heslin R, Ryan M. Advancing recovery in Ire-
land: a guidance paper on implementing organisational and cultural
change in mental health services in Ireland. 2016.
[40] Amering M, Schrank B, Wallcraft J. In: Amering M, Schrank B,
Wallcraft J, eds. Handbook of service user involvement in mental health
research. Chichester: Wiley-Blackwell, 2009.
[41] Horgan A, Manning F, Bocking J et al. ‘To be treated as a human’: using
co-production to explore experts by experience involvement in mental
health nursing education – the COMMUNE project. Int J Ment Health
Nurs 2018;27:1282–91.
[42] Pinfold V, Szymczynska P, Hamilton S et al. Co-production in mental
health research: reflections from the people study. Ment Health Rev
2015;20:220–31.
[43] Billsborough J, Mailey P, Hicks A et al. Listen, empower us and take
action now!’: reflexive-collaborative exploration of support needs in bipo-
lar disorder when ’going up’ and ’going down. J Ment Health 2014;23:
9–14.
[44] Happell B, Roper C. Consumer participation in mental health research:
articulating a model to guide practice. Aust N Z J Psychiatry 2007;15:
237–41.
[45] Cairns J, Nicholls J. Co-production in substance use research. Drugs
Alcohol Today 2018;18:6–16.
[46] Crapanzano K, Hammarlund R, Ahmad B, Hunsinger N, Kullar R. The
association between perceived stigma and substance use disorder treat-
ment outcomes: a review. Subst Abuse Rehabil 2018;10:1–12.
4 Commentary
© 2021 The Authors. Drug and Alcohol Review published by John Wiley & Sons Australia, Ltd on behalf of Australasian Professional Society on Alcohol and other Drugs.
